BlueSkeye AI uses artificial intelligence to detect mental health disorders. Founded in 2019 by Professor Michel Valstar (CEO), Dr Anthony Brown (CTO), and Chief Machine Learning and Software Engineer Dr Timur Almaev, the company is on a mission to improve well-being and patient outcomes.
Commenting on the investment, Professor Michel Valstar said, “we’ll strengthen the rollout of new clinical trials and product development and champion the benefits of technology for reinforcing healthcare provision on a national, regional and global basis.”
Marriott Harrison client, XTX Ventures, is an early-stage VC investing in companies with machine learning as a core technology. By leveraging XTX Markets’ world-leading expertise in machine learning, XTX Ventures grows and enhances its portfolio businesses.
#artificialintelligence #venturecapital #mentalhealth